Mukherjee Labs Preclinical Imaging

Design and Development of Novel Imaging Methods for Early Diagnosis of Diseases

You are here: Home / Publications / Schizophrenia

Schizophrenia

 

  • Mitelman, S.A., Buchsbaum, M.S., Christian, B.T., Merrill, B.M., Buchsbaum, B.R., Mukherjee, J., Lehrer, D.S. Positive association between cerebral gray matter metabolism and dopamine D2/D3 density in healthy and schizophrenia subjects: a dual-tracer 18F-fluorodeoxyglucose and 18F-fallypride positron emission tomography study. World Journal of Biological Psychiatry, online, September 2019. https://doi.org/10.1080/15622975.2019.1671609

 

  • Mitelman, S.A., Buchsbaum, M.S., Christian, B.T., Merrill, B.M., Buchsbaum, B.R., Mukherjee, J., Lehrer, D.S. Dopamine receptor density and white matter integrity: 18F-Fallypride positron emission tomography and diffusion tensor imaging study in healthy and schizophrenia subjects. Brain Imaging and Behavior, online doi.org/10.1007/s11682-018-0012-0, 2019.

 

  • Vyas, N.S., Buchsbaum, M.S., Lehrer, D.S., Merrill, B., DeCastro A, Doninger, N.A., Christian, B.T., Mukherjee, J.: D2/D3 dopamine receptor binding with [F-18]fallypride correlates of executive function in medication-naïve patients with schizophenia.  Schizophrenia Research, 192: 442-456, 2018.

 

  • Potkin, S.G., Keator, D.B., Kesler-West, M.L., Nguyen, D.D., van Erp, T.G.M., Mukherjee, J., Shah, N., Preda, A. D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizophrenia disorder. CNS Spectrums, doi:10.1017/S109285291300059X, 2013 (published on line October 2013).

 

  • Reist, C., Mukherjee, J., Wu, J; Modulating blood-brain barrier permeability and treatment-resistant psychiatric illness: Is pituitary neuroimaging a new frontier? Curr. Pharmacogenomics Personalized Med., 10, 182-184, 2012.

 

  • Ketoconazole-associated preferential increase in dopamine D2 receptor occupancy in striatum compared to pituitary in vivo: role for drug transporters? Reist C, Wu JC, Lilja Y, Mukherjee J, Gripeos D, Constantinescu C, Raggi MA, Mercolini L, Ozdemir V. J Clin Psychopharmacol. 2012 Feb;32(1):110-3. doi: 10.1097/JCP.0b013e3182408fc8. PMID: 22198458

 

  • D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia. Buchsbaum MS, Christian BT, Lehrer DS, Narayanan TK, Shi B, Mantil J, Kemether E, Oakes TR, Mukherjee J. Schizophr Res. 2006 Jul;85(1-3):232-44. Epub 2006 May 19. PMID: 16713185